对efgartigimod作为肌危机的有效治疗方法进行系统审查
Ping Tang1, Yi He1,2, Kaiqiang Xiao1,3
1Department of Neurology, First Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Naunyn-Schmiedeberg's archives of pharmacology
|February 27, 2025
概括
通过降低抗体水平,efgartigimod在治疗肌危机 (MC) 中表现有前途. 这种新生儿Fc受体抑制剂在所有接受治疗的MC患者中带来了显著的改善,需要进一步调查.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 作为新生儿Fc受体 (FcRn) 抑制剂的efgartigimod已被批准用于一般化骨髓灰质炎 (gMG).
- 目前没有针对efgartigimod在治疗肌危机 (MC) 的临床试验.
研究的目的:
- 系统地审查efgartigimod在治疗肌痛性危机 (MC) 的临床疗效.
主要方法:
- 在PubMed,Web of Science,Embase和Scopus数据库中进行了系统的文献搜索.
- 包括到2024年9月30日发表的观察性研究.
- 使用Joanna Briggs Institute (JBI) 批判性评估清单进行了偏差风险评估.
主要成果:
- 包括9项观察性研究 (病例报告/系列),涉及20名MC患者.
- 所有20名患者在治疗efgartigimod后都显示出临床显著的改善.
- 观察到抗乙胆受体 (AChR) 抗体标位和IgG水平持续下降.
结论:
- 埃夫加蒂格莫德在治疗肌痛性危机 (MC) 中表现出良好的临床疗效.
- 对MC患者来说,efgartigimod可能是一个有效的治疗选择.
- 需要进一步的研究来澄清efgartigimod作为单一疗法的疗效.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
01:15Myasthenia Gravis: Diagnostic Tests
597
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
597
01:30Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22
01:28Disorders of the Skeletal Muscle
849
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
849
01:26Heart Failure Drugs: Inotropic Agents
495
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
495
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
222
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
222